DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Invega (Paliperidone) - Drug Ineffective - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Ineffective (30)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 30   Next >>

Possible Invega side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-08-27

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Drug Ineffective, Suicide Attempt, Albumin Urine Present, Medication Residue

Drug(s) suspected as cause:
Invega

Other drugs received by patient: Bupropion HCL; Clonazepam



Possible Invega side effects in

Reported by a physician from Canada on 2012-08-16

Patient:

Reactions: Hallucination, Auditory, Drug Ineffective, Restlessness, Dizziness, Somnolence

Drug(s) suspected as cause:
Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Invega Sustenna
    Indication: Product Used FOR Unknown Indication

Invega Sustenna



Possible Invega side effects in 12 year old male

Reported by a physician from United States on 2012-08-08

Patient: 12 year old male

Reactions: Irritability, Swelling Face, Drug Ineffective, Pain in Extremity, Vision Blurred, Headache, Swollen Tongue

Drug(s) suspected as cause:
Invega

Other drugs received by patient: Concerta



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: female, weighing 95.3 kg (209.6 pounds)

Reactions: Abdominal Pain, Tachycardia, Headache, Palpitations, DRY Mouth, Postmenopausal Haemorrhage, Urinary Retention, Crying, Diabetes Mellitus Inadequate Control, Hypotension, Hyperprolactinaemia, Pituitary Tumour, Panic Disorder, Diabetic Coma, Vision Blurred, Electrocardiogram QT Prolonged, Hypersensitivity, Drug Ineffective, Drug Interaction, Disorientation, Constipation, Somnolence, Mania, Abdominal Distension, Dizziness, Decreased Appetite, Vomiting, Nausea, Retching, Muscular Weakness, Amnesia, Renal Failure Chronic, Anxiety, Blood Glucose Decreased, Bipolar Disorder, Eye Swelling, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2008-09-01
    End date: 2008-09-01

Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Start date: 2008-09-01
    End date: 2008-09-01

Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Other drugs received by patient possibly interacting with the suspect drug:
Haldol
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2008-09-26

Haldol
    Administration route: Oral

Haldol
    Dosage: 5 mg 1 in the am, 5 mg 1 in the pm and 5 mg as needed
    Administration route: Oral
    Start date: 1976-01-01

Other drugs received by patient: Other Therapeutic Medications; Depakote; Labetalol HCL; Allopurinol; Ibuprofen; Albuterol; Simvastatin; Depakote ER; Prevacid; Acetaminophen; Cozaar; Serevent; Abilify; Clonazepam; Restoril; Benadryl; Flovent; Zyprexa



Possible Invega side effects in male

Reported by a physician from Philippines on 2012-06-26

Patient: male

Reactions: Drug Ineffective, Hypoglycaemia, Urinary Incontinence, Intentional Drug Misuse, Throat Tightness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    End date: 2012-06-11

Invega Sustenna
    Indication: Schizophrenia
    Start date: 2012-06-11

Risperdal Consta
    Indication: Schizophrenia
    End date: 2012-06-11

Glipizide
    Dosage: 4 tablets per meal
    Indication: Product Used FOR Unknown Indication



Possible Invega side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Invega side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Invega side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-29

Patient: female, weighing 50.8 kg (111.8 pounds)

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2012-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-11-14
    End date: 2012-01-01

Other drugs received by patient: Citalopram; Citalopram



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: male

Reactions: Drug Ineffective

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: male

Reactions: Cataract, Drug Ineffective, Adverse Drug Reaction, Squamous Cell Carcinoma of Skin

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997

Chlorpromazine
    Indication: Hallucination

Risperdal
    Start date: 2011-01-01

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Hallucination

Risperdal Consta

Chlorpromazine
    Indication: Schizophrenia

Risperdal
    Start date: 2011-01-01

Risperdal
    Indication: Schizophrenia
    Start date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Autism

Other drugs received by patient: Levothyroxine Sodium; Depakote; Diphenhydramine HCL; Fluvoxamine Maleate; Paxil; Benztropine Mesylate; Benztropine Mesylate; Lorazepam



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: male

Reactions: Drug Ineffective, Abnormal Behaviour

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type

Invega Sustenna
    Indication: Schizophrenia, Paranoid Type
    Start date: 2012-02-03



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Invega side effects in male

Reported by a physician from Australia on 2012-02-15

Patient: male

Reactions: Malaise, Drug Ineffective

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zuclopenthixol
    Dosage: depot 200mg/250mg
    Indication: Product Used FOR Unknown Indication

Invega Sustenna
    Indication: Schizophrenia

Invega
    Indication: Schizophrenia

Clozapine
    Indication: Product Used FOR Unknown Indication

Invega Sustenna

Clozapine



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-10

Patient: female, weighing 50.8 kg (111.8 pounds)

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-11-14
    End date: 2012-01-01

Invega
    Administration route: Oral
    Start date: 2012-01-01

Other drugs received by patient: Citalopram Hydrobromide; Citalopram Hydrobromide



Possible Invega side effects in

Reported by a physician from Thailand on 2012-02-01

Patient:

Reactions: Drug Ineffective, Depression, Cognitive Disorder

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2012-01-25

Invega
    Administration route: Oral

Invega
    Administration route: Oral
    Indication: Schizophrenia



Possible Invega side effects in

Reported by a physician from United States on 2012-01-13

Patient:

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-13

Patient: male, weighing 72.6 kg (159.7 pounds)

Reactions: Weight Increased, Drug Ineffective, Retrograde Ejaculation

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2011-09-01

Invega
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2012-01-01

Other drugs received by patient: Depakote



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-11

Patient: male, weighing 99.8 kg (219.5 pounds)

Reactions: Photosensitivity Reaction, Drug Ineffective, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Indication: Schizoaffective Disorder

Invega
    Dosage: 2 tablets in the morning; 5 tablets bedtime
    Administration route: Oral
    Start date: 2011-09-01

Geodon
    Indication: Schizoaffective Disorder
    End date: 2011-01-01

Invega
    Administration route: Oral
    Indication: Schizoaffective Disorder



Possible Invega side effects in 26 year old female

Reported by a consumer/non-health professional from United States on 2012-01-03

Patient: 26 year old female

Reactions: Fatigue, Drug Ineffective, Increased Appetite, Heart Rate Increased, Insomnia, Anger, Abnormal Loss of Weight, Stress

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2011-12-22

Invega
    Administration route: Oral
    Indication: Bipolar I Disorder

Other drugs received by patient: TPN; Bilatin; Flax Seed OIL; Eveninig Primrose OIL; Vitamin D; Horse Chestnut Extract; 5 HTP; Hops



Possible Invega side effects in female

Reported by a physician from United States on 2011-12-28

Patient: female, weighing 95.3 kg (209.6 pounds)

Reactions: Abdominal Pain, Tachycardia, Headache, Palpitations, DRY Mouth, Postmenopausal Haemorrhage, Urinary Retention, Diabetes Mellitus Inadequate Control, Crying, Hypotension, Hyperprolactinaemia, Pituitary Tumour, Panic Disorder, Diabetic Coma, Vision Blurred, Electrocardiogram QT Prolonged, Hypersensitivity, Drug Ineffective, Drug Interaction, Disorientation, Constipation, Somnolence, Mania, Abdominal Distension, Dizziness, Decreased Appetite, Vomiting, Nausea, Retching, Muscular Weakness, Renal Failure Chronic, Amnesia, Blood Glucose Decreased, Anxiety, Bipolar Disorder, Eye Swelling, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2008-09-01
    End date: 2008-09-01

Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2008-01-01
    End date: 2008-01-01

Invega
    Administration route: Oral
    Start date: 2008-09-01
    End date: 2008-09-01

Invega
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2008-01-01

Other drugs received by patient possibly interacting with the suspect drug:
Haldol
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2008-09-26

Haldol
    Administration route: Oral

Haldol
    Dosage: 5 mg 1 in the am, 5 mg 1 in the pm and 5 mg as needed
    Administration route: Oral
    Start date: 1976-01-01

Other drugs received by patient: Restoril; Allopurinol; Acetaminophen; Albuterol; Depakote ER; Ibuprofen; Cozaar; Prevacid; Serevent; Abilify; Zyprexa; Other Therapeutic Medications; Benadryl; Depakote; Flovent; Labetalol HCL; Clonazepam; Simvastatin



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2011-12-23

Patient: female

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Hallucination, Tactile
    Start date: 2011-12-01

Invega
    Administration route: Oral
    Indication: Hallucination, Tactile
    Start date: 2011-12-01



Possible Invega side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-14

Patient: male

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega
    Dosage: 6mg + 6mg
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-01-01
    End date: 2011-01-01

Invega
    Administration route: Oral
    Start date: 2011-01-01



Possible Invega side effects in 51 year old male

Reported by a physician from Switzerland on 2011-10-24

Patient: 51 year old male

Reactions: Drug Ineffective, Libido Decreased, Erectile Dysfunction, Bulimia Nervosa

Drug(s) suspected as cause:
Paliperidone
    Indication: Psychotic Disorder
    Start date: 2011-09-28

Cymbalta
    Administration route: Oral
    Indication: Depression

Cymbalta
    Administration route: Oral
    Indication: Bipolar Disorder

Paliperidone
    Start date: 2011-09-20

Invega
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2011-09-01
    End date: 2011-09-01



Possible Invega side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-17

Patient: female

Reactions: Drug Ineffective, Incorrect Storage of Drug

Drug(s) suspected as cause:
Invega



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017